These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

911 related items for PubMed ID: 22535858

  • 1. Botulinum toxin A for prophylactic treatment of migraine and tension headaches in adults: a meta-analysis.
    Jackson JL, Kuriyama A, Hayashino Y.
    JAMA; 2012 Apr 25; 307(16):1736-45. PubMed ID: 22535858
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of botulinum toxin type A for the prophylaxis of episodic migraine headaches: a meta-analysis of randomized, double-blind, placebo-controlled trials.
    Shuhendler AJ, Lee S, Siu M, Ondovcik S, Lam K, Alabdullatif A, Zhang X, Machado M, Einarson TR.
    Pharmacotherapy; 2009 Jul 25; 29(7):784-91. PubMed ID: 19558252
    [Abstract] [Full Text] [Related]

  • 3. Botulinum toxins for the prevention of migraine in adults.
    Herd CP, Tomlinson CL, Rick C, Scotton WJ, Edwards J, Ives N, Clarke CE, Sinclair A.
    Cochrane Database Syst Rev; 2018 Jun 25; 6(6):CD011616. PubMed ID: 29939406
    [Abstract] [Full Text] [Related]

  • 4. Botulinum toxin A and headache treatment.
    Gady J, Ferneini EM.
    Conn Med; 2013 Mar 25; 77(3):165-6. PubMed ID: 23589955
    [Abstract] [Full Text] [Related]

  • 5. Botulinum toxin type A as an effective prophylactic treatment in primary headache disorders.
    Blumenfeld A.
    Headache; 2003 Sep 25; 43(8):853-60. PubMed ID: 12940806
    [Abstract] [Full Text] [Related]

  • 6. Botulinum Toxin versus Placebo: A Meta-Analysis of Prophylactic Treatment for Migraine.
    Bruloy E, Sinna R, Grolleau JL, Bout-Roumazeilles A, Berard E, Chaput B.
    Plast Reconstr Surg; 2019 Jan 25; 143(1):239-250. PubMed ID: 30589800
    [Abstract] [Full Text] [Related]

  • 7. Preventative treatment for migraine and tension-type headaches : do drugs having effects on muscle spasm and tone have a role?
    Freitag FG.
    CNS Drugs; 2003 Jan 25; 17(6):373-81. PubMed ID: 12696998
    [Abstract] [Full Text] [Related]

  • 8. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
    Aurora SK, Gawel M, Brandes JL, Pokta S, Vandenburgh AM, BOTOX North American Episodic Migraine Study Group.
    Headache; 2007 Apr 25; 47(4):486-99. PubMed ID: 17445098
    [Abstract] [Full Text] [Related]

  • 9. [Botulinum toxin injections for chronic migraine in adolescents - an early therapeutic option in the transition from neuropaediatrics to neurology].
    Bernhard MK, Bertsche A, Syrbe S, Weise S, Merkenschlager A.
    Fortschr Neurol Psychiatr; 2014 Jan 25; 82(1):39-42. PubMed ID: 24446117
    [Abstract] [Full Text] [Related]

  • 10. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R, Schreiber C.
    Headache; 2008 Jun 25; 48(6):900-13. PubMed ID: 18047501
    [Abstract] [Full Text] [Related]

  • 11. Cochrane systematic review and meta-analysis of botulinum toxin for the prevention of migraine.
    Herd CP, Tomlinson CL, Rick C, Scotton WJ, Edwards J, Ives NJ, Clarke CE, Sinclair AJ.
    BMJ Open; 2019 Jul 16; 9(7):e027953. PubMed ID: 31315864
    [Abstract] [Full Text] [Related]

  • 12. Impact of the botulinum-A toxin on prevention of adult migraine disorders.
    Shen B, Wang L.
    J Integr Neurosci; 2020 Mar 30; 19(1):201-208. PubMed ID: 32259898
    [Abstract] [Full Text] [Related]

  • 13. Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study.
    Dodick DW, Mauskop A, Elkind AH, DeGryse R, Brin MF, Silberstein SD, BOTOX CDH Study Group.
    Headache; 2005 Apr 30; 45(4):315-24. PubMed ID: 15836567
    [Abstract] [Full Text] [Related]

  • 14. Botulinum toxin type A for the treatment of migraine.
    Aurora S.
    Expert Opin Pharmacother; 2006 Jun 30; 7(8):1085-95. PubMed ID: 16722818
    [Abstract] [Full Text] [Related]

  • 15. Botulinum toxin for subacute/chronic neck pain.
    Langevin P, Peloso PM, Lowcock J, Nolan M, Weber J, Gross A, Roberts J, Goldsmith CH, Graham N, Burnie SJ, Haines T.
    Cochrane Database Syst Rev; 2011 Jul 06; (7):CD008626. PubMed ID: 21735434
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of Botulinum Toxin in Tension-Type Headaches: A Systematic Review of the Literature.
    Freund B, Rao A.
    Pain Pract; 2019 Jun 06; 19(5):541-551. PubMed ID: 30742360
    [Abstract] [Full Text] [Related]

  • 17. Botulinum toxin type A as a migraine preventive treatment. For the BOTOX Migraine Clinical Research Group.
    Silberstein S, Mathew N, Saper J, Jenkins S.
    Headache; 2000 Jun 06; 40(6):445-50. PubMed ID: 10849039
    [Abstract] [Full Text] [Related]

  • 18. Botulinum toxin in migraine prophylaxis.
    Göbel H.
    J Neurol; 2004 Feb 06; 251 Suppl 1():I8-11. PubMed ID: 14991336
    [Abstract] [Full Text] [Related]

  • 19. Botulinum toxin for chronic migraine.
    Med Lett Drugs Ther; 2011 Jan 24; 53(1356):7-8. PubMed ID: 21252842
    [No Abstract] [Full Text] [Related]

  • 20. Botulinum neurotoxin for the treatment of migraine and other primary headache disorders: from bench to bedside.
    Dodick DW.
    Headache; 2003 Jan 24; 43 Suppl 1():S25-33. PubMed ID: 12887391
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.